glp-1 and kidney disease GLP-1s started in diabetes. Now they span heart failure, disease, sleep apnea, fatty liver, osteoarthritis, conditions that rank among the leading causes of death in Western society. As per_box Flavor:Candy Rush Demand for GLP-1 presents

glp-1 and kidney disease GLP-1s started in diabetes. Now they span heart failure, disease, sleep apnea, fatty liver, osteoarthritis, conditions that rank among the leading causes of death in Western society. As per_box Flavor:Candy Rush Demand for GLP-1 presents

Demand for GLP-1 presents challenges for pharma industry

A recent systematic review of oral probiotic interventions in metabolic disorders reported modest but consistent improvements in glycemic parameters, including fasting glucose and HbA1c, alongside signals of enhanced incretin activity, supporting a mechanistic link between probiotic supplementation and gut hormone regulation (109)

per_box

Flavor:Candy Rush

doi: 10.1210/endo.140.11.7143 30 DeaconCF